Acute SGLT2 Inhibition and the Pressure Natriuresis Response in Rats with Type 1 Diabetes

被引：0
|
作者：
Bailey, Matthew A.
Costello, Hannah M.
Stewart, Kevin
Binnie, David
Culshaw, Geoffrey C.
Webb, David J.
机构：
来源：
FASEB JOURNAL | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
569.10
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Sodium-glucose cotransporter 2 inhibition does not improve the acute pressure natriuresis response in rats with type 1 diabetes
    Jones, Natalie K.
    Costello, Hannah M.
    Monaghan, Marie-Louise T.
    Stewart, Kevin
    Binnie, David
    Marks, Joanne
    Bailey, Matthew A.
    Culshaw, Geoffrey J.
    EXPERIMENTAL PHYSIOLOGY, 2023, 108 (03) : 480 - 490
  • [2] Does SGLT1 Inhibition Add Benefit to SGLT2 Inhibition in Type 2 Diabetes?
    Pitt, Bertram
    Bhatt, Deepak L.
    CIRCULATION, 2021, 144 (01) : 4 - 6
  • [3] SGLT2 IN TYPE 1 DIABETES - EFFICACY
    Mathieu, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A6 - A6
  • [4] SGLT2 Inhibition Suppresses Glucagon Response to Hypoglycemia in Male but Not Female Rats with Streptozotocin-Induced Type 1 Diabetes
    Greenberg, Caylee A.
    Mandel, Erin R.
    Pasieka, Aoibhe M.
    Jahangiriesmaili, Mahsa
    Tremblay, Julie
    Riddell, Michael
    DIABETES, 2019, 68
  • [5] Mechanistic effects of SGLT2 inhibition on blood pressure in diabetes
    Yaribeygi, Habib
    Atkin, Stephen L.
    Sahebkar, Amirhossein
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (02) : 1679 - 1683
  • [6] The Effect of SGLT2 Inhibition on Adenosine Excretion in Patients with Type 1 Diabetes
    Rajasekeran, Harindra
    Lytvyn, Yuliya
    Bozovic, Andrea
    Diamandis, Eleftherios
    Husain, Mansoor
    Advani, Andrew
    Perkins, Bruce A.
    Reich, Heather
    Kulasingam, Vathany
    Cherney, David
    DIABETES, 2016, 65 : A144 - A144
  • [7] A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes
    Sokolov, Victor
    Yakovleva, Tatiana
    Stolbov, Leonid
    Penland, Robert C.
    Boulton, David
    Parkinson, Joanna
    Tang, Weifeng
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (06): : 831 - 841
  • [8] Type 1 diabetes: SGLT2 inhibition optimizes renal energy metabolism
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (02) : 101 - 102
  • [9] SGLT2 inhibition: efficacy and safety in type 2 diabetes treatment
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (12) : 1879 - 1904
  • [10] SGLT2 inhibitors in Type 1 diabetes: is this the future?
    Herring, R.
    Russell-Jones, D. L.
    DIABETIC MEDICINE, 2018, 35 (12) : 1642 - 1643
12345